How an increased focus on people has helped companies survive the pandemic. As COVID has moved through the pharma industry, there has been a reshaping of the workforce. With a new premium put on people, companies have become more in tune with employee initiatives and have made a number of adjustments. A new COVID workforce, […]

While the development of cell therapies today is largely focused on oncology indications, some companies, including Athersys, envision a future where these therapies could treat other diseases and conditions, such as cardiovascular disease. B.J. Lehmann, interim CEO of Athersys, spoke with ScienceBoard.net about a recent panel that he participated in at the Cell & Gene Meeting on […]

Boys with autism spectrum disorder who received 10 mg/kg of a suramin IV infusion known as PAX-101 experienced greater improvements in symptoms than those who received 20 mg/kg of the same treatment or placebo, data show. According to the CDC, one in 54 children in the U.S. had ASD in 2016, up from one in 150 children […]